This issue of the CAPS Newsletter discusses the following topics: 

• X-DEA Prescription Requirements
• Prescriptions Written by a Nurse Practitioner (NP) or Physician Assistant (PA)
• Insulin Part B vs. Part D Billing
• NDC Number does NOT mean a Product is "FDA Approved"
• PBM Processing Exclusion for Non-FDA Approved Drugs
• “Use as Directed”, “As Directed”, “Per Sliding Scale” Directions
• Prescription Origin Codes
• DAW Codes (According to CMS.gov)
• OIG/SAM Monthly Exclusion Checks 
• CAPS Department Contact Information

*Please see attached PDF for the revised communication to reflect the correct Line of Business.

Effective January 1, 2017, CVS Caremark® will exclude coverage for all new-to-market unapproved products and certain existing unapproved products that may be marketed contrary to the Federal Food, Drug, and Cosmetic Act (FFDCA). Coverage will remain for select unapproved products that are legally marketed(1) or deemed clinically necessary (e.g., because no alternatives exist).

*Please see attached PDF for more information.

All the week's generic news in one spot!

Effective September 1, 2015, Blue Cross Blue Shield of Minnesota will no longer cover prescription claims for the topical patches identified below, as they are not approved by the U.S. Food and Drug Administration (FDA).